FLUZONE QUADRIVALENT
FLUZONE QUADRIVALENT
Discontinued
DIN Number
02420635
Drug Class
Human
Market Date
N/A
Company
HC
Sanofi Pasteur Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02420635
AIG Number0455410001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
HAEMAGGLUTININ-STRAIN A (H1N1)Active
Strength: 7.5 MCG / 0.25 ML
Monograph: HAEMAGGLUTININ-STRAIN A (H1N1)
HAEMAGGLUTININ-STRAIN A (H3N2)Active
Strength: 7.5 MCG / 0.25 ML
Monograph: HAEMAGGLUTININ-STRAIN A (H3N2)
HAEMAGGLUTININ-STRAIN B (VICTORIA)Active
Strength: 7.5 MCG / 0.25 ML
Monograph: HAEMAGGLUTININ-STRAIN B (VICTORIA)
HAEMAGGLUTININ-STRAIN B (YAMAGATA)Active
Strength: 7.5 MCG / 0.25 ML
Monograph: HAEMAGGLUTININ-STRAIN B (YAMAGATA)